Exercise and Intranasal Insulin in Type 2 Diabetes
NCT07675499
This study is recruiting at 4 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
About 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise may help reduce the risk of dementia by increased blood flow to the brain and help the brain respond better to insulin.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Type 2 Diabetes
- Insulin Sensitivity/Resistance
- Cognition
- Brain Blood Flow
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2/3
- Ages
- 55 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Rutgers, The State University of New Jersey
- Last updated on ClinicalTrials.gov
- June 30, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 4
- Institute for Food, Nutrition, and Health · New Brunswick, NJ
- Robert Wood Johnson University Hospital Clinical Research Center · New Brunswick, NJ
- Rutgers University Loree Gymnasium · New Brunswick, NJ
- Center for Advanced Human Brain Imaging Research · Piscataway, NJ
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.